Clinical Adverse Effects of Endothelin Receptor Antagonists: Insights From the Meta‐Analysis of 4894 Patients From 24 Randomized Double‐Blind Placebo‐Controlled Clinical Trials

BACKGROUND: Evidence of the clinical safety of endothelin receptor antagonists (ERAs) is limited and derived mainly from individual trials; therefore, we conducted a meta‐analysis. METHODS AND RESULTS: After systematic searches of the Medline, Embase, and Cochrane Library databases and the ClinicalT...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Anhua, Gu, Zhichun, Li, Juan, Liu, Xiaoyan, Wu, Xiaofan, Han, Yi, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210319/
https://www.ncbi.nlm.nih.gov/pubmed/27912207
http://dx.doi.org/10.1161/JAHA.116.003896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210319/
https://www.ncbi.nlm.nih.gov/pubmed/27912207
http://dx.doi.org/10.1161/JAHA.116.003896

Ejemplares similares